Genus PLC (GNS.L)
GNS.L on London Stock Exchange
23 Aug 2019
23 Aug 2019
Change (% chg)
|72||2010||Non-Executive Independent Chairman of the Board|
|2011||Chief Executive, Executive Director|
|2013||Group Finance Director, Executive Director|
|2018||Chief Research & Development and Scientific Officer|
|2014||Group General Counsel & Company Secretary|
|2017||Group Human Resources Director|
|2013||Chief Operating Officer - Genus PIC|
|2016||Chief Operating Officer - Genus ABS Beef|
|2017||Chief Operating Officer - Genus ABS Dairy|
|2018||Non-Executive Independent Director|
|2016||Non-Executive Independent Director|
|65||2018||Non-Executive Independent Director|
|2014||Non-Executive Independent Director|
|2017||IR Contact Officer|
|Mr. Robert A. Lawson, (Bob) serves as Non-Executive Independent Chairman of the Board of Genus PLC. He has significant experience of leading international businesses, including through operational and culture changes, and a deep understanding of listed companies and corporate governance. Current Appointments : Non-Executive Chairman of Eurocell plc. Past Appointments : Chief Executive of Electrocomponents plc, Managing Director of Vitec Group plc, Chairman of the Federation of Groundwork Trusts, Chairman of Hays plc, and Non-Executive Chairman of Barratt Developments plc.|
|Mr. Karim Bitar is no longer Chief Executive, Executive Director of Genus PLC., effective 16 September 2019. He has extensive experience of leading international, science-based organisations. His strategic review of Genus in 2012 resulted in a new vision, strategy, structure and core values. He has a BSc in Biochemistry from the University of Wisconsin and an MBA from the University of Michigan. Current Appointments : Non-Executive Director of Spectris plc and member of the University of Michigan Ross School of Business Advisory Board. Past Appointments President of Lilly Europe, Canada and Australia; McKinsey and Company consultant; and management roles at Johnson and Johnson, and the Dow Chemical Company.|
|Mr. Stephen Wilson serves as Group Finance Director, Executive Director of Genus PLC. He has worked in France and the US and has wide-ranging experience of mergers and acquisitions, financing, strategy and investor relations. He is a Fellow of the Chartered Institute of Management Accountants and holds a degree in Mathematics from the University of Cambridge. Past Appointments : Executive Vice President and Chief Financial Officer of Misys plc; finance and business development roles at IBM; and Non- Executive Director and Audit Committee Chair of Xchanging plc.|
|Dr. Jonathan Lightner serves as Chief Research & Development and Scientific Officer of Genus PLC. Skills and Experience : Quantitative molecular geneticist, with expertise spanning molecular biology, analytical chemistry and biotechnologies, Extensive regulatory and commercial experience, BS in Biology, Masters in Systems Engineering from Iowa State, MBA from the University of Iowa and Doctorate in Plant Physiology from the Institute of Biological Chemistry at Washington State University. He has Over 25 years of industrial experience, applying biotechnology to creating solutions for farmers, Ten years in variety of executive roles with Pioneer HI-Bred, including leading the global biotechnology team, Joined Genus in 2013 as Chief Scientific Officer and global head of R&D, Prior experience included three years with Exelixis, as Director of Biochemical Genomics.|
|Mr. Dan Hartley serves as Group General Counsel & Company Secretary of Genus PLC. He has significant experience in multi-jurisdictional patent litigation, mergers and acquisitions, patent licensing and managing product life cycles in complex areas. He holds degrees in science and law. Past Appointments : Senior Vice President and International Counsel of Shire plc; and senior and global roles in Australia, the UK and the US.|
|Ms. Angelle Rosata serves as Group Human Resources Director of the company. Angelle combines commercial acumen with her broad expertise in resourcing, talent and succession, leadership development, and H&S. Her strategic planning skills and pragmatism help to align the Group’s people agenda with its business needs. Angelle holds a Masters in Human Resource Development from Vanderbilt University. Angelle Joined Genus in September 2013, following more than 20 years in the healthcare sector., Developed and delivered PIC’s people strategy, before becoming HR Director for ABS and then Group HR Director on 1 July 2017.|
|Mr. Bill Christianson serves as Chief Operating Officer - Genus PIC of Genus PLC. He has spent his whole career at the intersection of agriculture and biotechnology. As a result, he brings a unique blend of deep industry knowledge and extensive commercial and global experience to Genus. He holds doctorates (DVM and PhD) in Veterinary Medicine from the University of Minnesota. He Joined Genus in 1993 and subsequently worked in operational roles spanning Europe, South America and the US, before becoming General Manager of PIC North America in 2007., Led the combined ABS and PIC business across the Americas from 2010, before becoming COO of Genus PIC in 2012.|
|Mr. Jerry Thompson serves as Chief Operating Officer - Genus ABS Beef of Genus PLC. Skills and Experience : A natural entrepreneur with deep industry knowledge, commercial skills and international experience. Has helped Genus establish and grow businesses in countries as diverse as the UK, Russia, India and China. Holds a degree in Agriculture from University of Plymouth and is a graduate of Harvard Business School’s Advanced Management Program. He Joined PIC in 1992, working initially in the UK and then Siberia and Romania, before leading PIC in Central and Eastern Europe and then Europe as a whole, Led PIC and ABS in Russia and Asia Pacific, before becoming COO for Genus Asia in 2012 and then COO for Genus ABS Beef in July 2016.|
|Dr. Nate Zwald serves as Chief Operating Officer - Genus ABS Dairy of Genus PLC. Skills and Experience Deep expertise and experience of dairy genetics, strong commercial focus and passion for people development. Board member of the Council on Dairy Cattle Breeding and Vice President of the National Association of Animal Breeders. Degree in Dairy Science, MBA and PhD in Dairy Cattle Genetics from the University of Wisconsin. Nate Joined Genus in January 2017 after 15 years at Alta Genetics, including 10 years as General Manager of its US business and more than two years as Global Marketing Director. Remains involved in his family’s commercial dairy operation, Bomaz farm in the US, which has produced high-ranking industry and ABS sires.|
|Prof. Ian Charles is Non-Executive Independent Director of the Company. Skills and Experience : Entrepreneurial scientist, with deep scientific expertise, More than 30 years’ experience in academic and commercial research institutions, Current research focus is infectious diseases, the microbiome and its impact on health and well-being. Current Appointments : Co-founder and Board Director of Auspherix; Board Director of Longas Technologies Pty Limited; and Director of Quadram Institute Bioscience. Past Appointments : Director of the ithree institute, University of Technology, Sydney; co-founder and Chief Scientific Officer of Arrow Therapeutics; founder member of The Wolfson Institute for BioMedical Research at University College London; and various roles at Glaxo Wellcome and Sheffield, Cambridge and Leicester Universities.|
|Ms. Lysanne Gray serves as Non-Executive Independent Director of the Company, since 1 April 2016. Lysanne has significant experience of risk management, audit, business operations, acquisitions and disposals, and corporate governance, gained within the food sector. She is a Chartered Accountant. Current Appointments : Financial Controller at Unilever plc and Unilever NV. Past Appointments : Chief Auditor of Unilever; Chief Financial Officer of Unilever’s global food service business; and a number of other senior operational and financial positions within Unilever.|
|Ms. Lesley Mary Samuel Knox is Non-Executive Independent Director of the Company. Current Appointments : Chair of Grosvenor Group and member of the Remuneration committee; Non-Executive Director of Thomas Cook; and Non-Executive Director and Chair of the Remuneration Committee of Legal & General. Past Appointments : Founder director of British Linen Advisors; Governor of British Linen Bank Group; and numerous non-executive roles, including Centrica, SAB Miller, Alliance Trust, Hays, Scottish Provident and Bank of Scotland.|
|Mr. Lykele Van der Broek serves as Non-Executive Independent Director of Genus PLC. He has vast experience of growing companies and working in agricultural businesses throughout the world, including in emerging markets. Current Appointments : Chair of Eden Research plc. Past Appointments : Member of the Board of Management of Bayer CropScience, a division of Bayer AG; senior international roles including the Head of Bayer CropScience’s BioScience division; and President of the Bayer HealthCare Animal Health division.|
|Name||Fiscal Year Total|
As Of 30 Jun 2018
- 3 Healthcare Stocks With More Downside Than Upside? Shire PLC, Alliance Pharma plc And Genus plc
- AstraZeneca plc, Smith & Nephew plc And Genus plc: Buy, Sell Or Hold?
- GlaxoSmithKline plc, Genus plc And Alliance Pharma plc: 3 Of The Best Health Care Stocks?
- Does Sepura Plc Offer More Value Than Genus plc & SDL plc After A 24% Rally?
- Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And Genus plc?
- Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?